Skip to content
healthcare.dev

CHOLESTYRAMINE

NDC 68382-529, CHOLESTYRAMINE, powder, for suspension, from Zydus Pharmaceuticals (USA) Inc..

Product NDC
68382-529
Status
Listed
Labeler
Zydus Pharmaceuticals (USA) Inc.
Dosage form
POWDER, FOR SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA202902
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68382-529 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CHOLESTYRAMINE4 g/5.5g

Pharmacologic classes

Bile Acid Sequestrant [EPC]; Bile-acid Binding Activity [MoA]

Package NDCNDC-11Package
68382-529-4268382052942231 g in 1 CONTAINER (68382-529-42)
68382-529-606838205296060 POUCH in 1 CARTON (68382-529-60) / 5.5 g in 1 POUCH

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/2dcf7652-0c3e-4bc3-abfd-20a5b3d2a4f4
  • NADAC price for package 68382052942

    GET /v1/drugs/nadac/68382052942
  • NADAC price for package 68382052960

    GET /v1/drugs/nadac/68382052960

Use it

Look up 68382-529 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68382-529 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68382-529. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.